Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Preferred Stock Liabilities: 2020-2021

  • GeneDx Holdings' Preferred Stock Liabilities was N/A to $334.4 million in Q2 2021 from the same period last year, while for Jun 2021 it was $334.4 million, marking a year-over-year change of. This contributed to the annual value of $334.4 million for FY2020, which is N/A change from last year.
  • As of Q2 2021, GeneDx Holdings' Preferred Stock Liabilities stood at $334.4 million, which was down 0.00% from $334.4 million recorded in Q1 2021.
  • In the past 5 years, GeneDx Holdings' Preferred Stock Liabilities ranged from a high of $334.4 million in Q4 2020 and a low of $334.4 million during Q4 2020.
  • Over the past 2 years, GeneDx Holdings' median Preferred Stock Liabilities value was $334.4 million (recorded in 2021), while the average stood at $334.4 million.